{"entity":{"id":"nct07891533","kind":"trial","name":"Phase 2 Study of Oral Epetraborole in Adults With Polycythemia Vera","aka":[],"tldr":"A phase 2 trial of Epetraborole run by AN2 Therapeutics, Inc, not yet recruiting.","summary":"Phase 2 Study of Oral Epetraborole in Adults With Polycythemia Vera is a phase 2 interventional study registered as NCT07891533 by AN2 Therapeutics, Inc, with 75 participants planned, started 2026-11, primary completion expected 2029-04. Conditions recorded: Polycythemia Vera (SNOMED CT: 109992005). Interventions recorded: Epetraborole, Placebo.","status":"planned","asOf":"2026-11-04","links":[{"label":"ClinicalTrials.gov NCT07891533","url":"https://clinicaltrials.gov/study/NCT07891533"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["polycythaemia-vera"],"sections":[],"technologies":[],"targets":[],"drugs":["epetraborole"],"companies":["an2-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07891533","phase":"2","setting":"A Phase 2 Study of the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Epetraborole Tablets for the Treatment of Adults With Phlebotomy-Dependent Polycythemia Vera","sponsor":"AN2 Therapeutics, Inc","enrolled":75,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07891533/","neighbours":{"cancer":[{"id":"polycythaemia-vera","kind":"cancer","name":"Polycythaemia vera (PV)","route":"/cancers/polycythaemia-vera/"}],"drug":[{"id":"epetraborole","kind":"drug","name":"Epetraborole","route":"/drugs/epetraborole/"}],"company":[{"id":"an2-therapeutics","kind":"company","name":"AN2 Therapeutics","route":"/companies/an2-therapeutics/"}]}}